avapro and cyclic gmp

avapro has been researched along with cyclic gmp in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bodenschatz, M; Hoffmann, N; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Skatchkov, M; Smolenski, A; Walter, U; Warnholtz, A	1
Batenburg, WW; Bernasconi, CC; Danser, AH; Garrelds, IM; Juillerat-Jeanneret, L; Saxena, PR; van Kats, JP	1
Briand, D; Canals, F; Galindo, G; Herbert, JM; Hogie, M; Lacour, C; Nisato, D; Roccon, A; Roque, C; Segondy, D	1
Azizi, M; Bissery, A; Floch, A; Guyene, TT; Ménard, J; Ozoux, ML; Peyrard, S	1

Trials

1 trial(s) available for avapro and cyclic gmp

Article	Year
Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans. Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:1 Topics: Adolescent; Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biotransformation; Biphenyl Compounds; Cross-Over Studies; Cyclic GMP; Dose-Response Relationship, Drug; Heterocyclic Compounds, 3-Ring; Humans; Irbesartan; Male; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Ramipril; Renin; Renin-Angiotensin System; Single-Blind Method; Tetrazoles	2006

Article

Year

Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.

Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:1

Topics: Adolescent; Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biotransformation; Biphenyl Compounds; Cross-Over Studies; Cyclic GMP; Dose-Response Relationship, Drug; Heterocyclic Compounds, 3-Ring; Humans; Irbesartan; Male; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Ramipril; Renin; Renin-Angiotensin System; Single-Blind Method; Tetrazoles

2006

Other Studies

3 other study(ies) available for avapro and cyclic gmp

Article	Year
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circulation research, 2000, Nov-24, Volume: 87, Issue:11 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Cell Adhesion Molecules; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Hyperlipidemias; In Vitro Techniques; Irbesartan; Microfilament Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Oxidative Stress; Phosphoproteins; Phosphorylation; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Serine; Signal Transduction; Superoxide Dismutase; Tetrazoles; Vasodilation; Vasodilator Agents	2000
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation, 2004, May-18, Volume: 109, Issue:19 Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Biphenyl Compounds; Child; Child, Preschool; Coronary Circulation; Coronary Vessels; Cyclic GMP; Female; Humans; Imidazoles; Irbesartan; Male; Microcirculation; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; RNA, Messenger; Tetrazoles; Vasodilation	2004
Effects of differential blockade of the renin-angiotensin system in postinfarcted rats. Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:3 Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cyclic GMP; Enalapril; Hemodynamics; Irbesartan; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tetrazoles; Ventricular Remodeling	2004